A Look At SELLAS Life Sciences Group (SLS) Valuation After New IMPACT AML Clinical Study Agreement

SELLAS Life Sciences Group (SLS) has entered an agreement with IMPACT-AML, a pan-European clinical network, to run a new ...
Stocktwits on MSN

SLS stock breaches $5 level after over 3 years: Retail now eyes buyout for as much as $25B

SELLAS is currently evaluating Galinpepimut-S (GPS) as a potential maintenance therapy in patients with Acute Myeloid ...

SELLAS Life Sciences Group (SLS) Is Up 50.8% After REGAL Trial Nears Final OS Trigger - Has The Bull Case Changed?

SELLAS Life Sciences Group recently reported that its Phase 3 REGAL trial of galinpepimut‑S (GPS) in Acute Myeloid Leukemia ...
Stocktwits on MSN

Why is SLS stock drawing significant investor attention today?

The company said that 72 out of the prespecified 80 deaths required to trigger the final analysis have now occurred as of Dec. 26, 2025. ・That extended survival timeline may delay the anticipated year ...
Benzinga.com

SELLAS Life Sciences Stock Is Surging Higher: What's Going On?

SELLAS Life Sciences Group Inc (NASDAQ: SLS) shares are trading higher on Monday after initially dropping in premarket trading, reversing course as investors seem to react to new trial‑related updates ...
Morningstar

MEDiC Life Sciences Acquires Clinical-Stage Oncology Program, Validating SLS Biomarker Platform

MEDiC Life Sciences, a leader in next-generation functional genomics in 3D cancer models, today announced the acquisition of a clinical-stage therapeutic program. This landmark acquisition is the ...